|
|
| | Tofacitinib Impurity Basic information |
| Product Name: | Tofacitinib Impurity | | Synonyms: | Tofacitinib Impurity ZJT1-F;(2-Chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-dimethyl-amine;7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 2-chloro-N,N-dimethyl-;(E)-methyl 3-amino-2-cyano-5-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-5-oxopent-2-enoate;2-Chloro-N,N-dimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine | | CAS: | 2282653-53-4 | | MF: | C8H9ClN4 | | MW: | 196.64 | | EINECS: | | | Product Categories: | | | Mol File: | 2282653-53-4.mol |  |
| | Tofacitinib Impurity Chemical Properties |
| density | 1.422±0.06 g/cm3(Predicted) | | pka | 12.47±0.50(Predicted) |
| | Tofacitinib Impurity Usage And Synthesis |
| | Tofacitinib Impurity Preparation Products And Raw materials |
|